Regeneron Pharmaceuticals, Inc. (REGN) — GAAP EPS actuals & earnings history
As-filed GAAP earnings, announcement timing (BMO/AMC), margins, and Form 4 insider transactions for Regeneron Pharmaceuticals, Inc. — every data point sourced from SEC EDGAR and auditable to the original filing.
Coverage2011-03 to 2026-06
Quarters62
Earnings quality100.0/100 (tier A)
SourceEDGAR
The quality score grades this ticker’s GAAP EPS series only. Form 4 and other modules use separate coverage checks in the quality report.
Recent GAAP EPS for REGN
A sample of the most recent as-filed diluted GAAP EPS. The full 2011-03 to 2026-06 history (62 quarters) is included in the Aegwah dataset.
| Fiscal quarter | Diluted EPS (GAAP) | Revenue | Filed | EDGAR |
|---|---|---|---|---|
| 2026Q2 | 12.23 | $4.29B | 2026-07-30 | 0000872589-26-000025 |
| 2026Q1 | 6.75 | $3.61B | 2026-04-29 | 0000872589-26-000016 |
| 2025Q3 | 13.62 | $3.75B | 2025-10-28 | 0000872589-25-000028 |
| 2025Q2 | 12.41 | $3.55B | 2025-08-01 | 0000872589-25-000019 |
| 2025Q1 | 6.27 | $3.15B | 2025-04-29 | 0001804220-25-000022 |
| 2024Q3 | 8.89 | $3.36B | 2024-10-31 | 0001804220-24-000040 |
| 2024Q2 | 8.5 | $3.16B | 2024-08-01 | 0001804220-24-000028 |
| 2024Q1 | 7.17 | $3.16B | 2024-05-02 | 0001804220-24-000017 |
What you get for REGN
- As-filed diluted & basic GAAP EPS (split-adjusted) for every reported quarter
- Revenue, net income, and gross margin where reported in XBRL
- Announcement timing — before-market (BMO) or after-market (AMC) from matched 8-K acceptance time
- Form 4 insider open-market buys & sells (Pro adds clusters & conviction scores)
- The SEC
edgar_accessionandfiling_urlon every EDGAR-sourced record
Access REGN data via API
The same membership unlocks a ZIP download and a Bearer-token REST API:
curl -H "Authorization: Bearer <your-key>" \
https://api.aegwah.com/v1/actuals/earnings/REGN
Get the full REGN history
All 502 S&P 500 + S&P 400 tickers, 16+ years of GAAP EPS, ZIP + REST API. From $30/month.
View plans →Related: how this data is sourced & scored · per-ticker quality report · REGN filings on SEC EDGAR